ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy

被引：2
|
作者：
Hilal, Talal [1 ]
Patel, Bhavika K. [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Div Hematol Oncol, Phoenix, AZ 85013 USA
[2] Mayo Clin, Dept Radiol, Phoenix, AZ USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2018年 / 25卷
关键词：
Contrast-enhanced Spectral Mammography (CESM); Residual Breast Cancer; Neoadjuvant Systemic Therapy (NST); HER2-positive Breast Cancer Subtypes; Gold Standard Comparison;
D O I：
10.1245/s10434-018-6899-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：652 / 653
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: Role of Contrast-Enhanced Spectral Mammography in the Assessment of Residual Breast Cancer After Neoadjuvant Systemic Therapy
    Talal Hilal
    Bhavika K. Patel
    [J]. Annals of Surgical Oncology, 2018, 25 : 652 - 653
  • [2] Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
    Patel, Bhavika K.
    Hilal, Talal
    Covington, Matthew
    Zhang, Nan
    Kosiorek, Heidi E.
    Lobbes, Marc
    Northfelt, Donald W.
    Pockaj, Barbara A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (05) : 1350 - 1356
  • [3] Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
    Bhavika K. Patel
    Talal Hilal
    Matthew Covington
    Nan Zhang
    Heidi E. Kosiorek
    Marc Lobbes
    Donald W. Northfelt
    Barbara A. Pockaj
    [J]. Annals of Surgical Oncology, 2018, 25 : 1350 - 1356
  • [4] Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer
    Elkassas, Hebatalla
    El-Maadawy, Samar M.
    Saad, Sherihan Mahmoud
    Radwan, Amira H.
    Gareer, Sherihan W. Y.
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2022, 53 (01):
  • [5] Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer
    Hebatalla Elkassas
    Samar M. El-Maadawy
    Sherihan Mahmoud Saad
    Amira H. Radwan
    Sherihan W. Y. Gareer
    [J]. Egyptian Journal of Radiology and Nuclear Medicine, 53
  • [6] ASO Author Reflections: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer
    MacCallum, Caroline
    Elder, Kenneth
    Nickson, Carolyn
    Ruecker, Kelly
    Park, Allan
    Mann, G. Bruce
    Rose, Allison K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [7] Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
    Steinhof-Radwanska, Katarzyna
    Grazynska, Anna
    Lorek, Andrzej
    Gisterek, Iwona
    Barczyk-Gutowska, Anna
    Bobola, Agnieszka
    Okas, Karolina
    Lelek, Zuzanna
    Morawska, Irmina
    Potoczny, Jakub
    Niemiec, Pawel
    Szyluk, Karol
    [J]. CURRENT ONCOLOGY, 2021, 28 (05) : 3448 - 3462
  • [8] Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment
    Hogan, Molly P.
    Horvat, Joao V.
    Ross, Dara S.
    Sevilimedu, Varadan
    Jochelson, Maxine S.
    Kirstein, Laurie J.
    Goldfarb, Shari B.
    Comstock, Christopher E.
    Sung, Janice S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 349 - 359
  • [9] Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment
    Molly P. Hogan
    Joao V. Horvat
    Dara S. Ross
    Varadan Sevilimedu
    Maxine S. Jochelson
    Laurie J. Kirstein
    Shari B. Goldfarb
    Christopher E. Comstock
    Janice S. Sung
    [J]. Breast Cancer Research and Treatment, 2023, 198 : 349 - 359
  • [10] ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients
    van Loevezijn, Ariane A.
    van Duijnhoven, Frederieke H.
    Vrancken Peeters, Marie-Jeanne T. F. D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3254 - 3255
12345